Literature DB >> 29898965

B7-H4 Modulates Regulatory CD4+ T Cell Induction and Function via Ligation of a Semaphorin 3a/Plexin A4/Neuropilin-1 Complex.

Joseph R Podojil1, Ming-Yi Chiang1, Igal Ifergan1, Ronald Copeland2, Linda N Liu2, Sebastien Maloveste2, Solomon Langermann2, David Liebenson3, Roumen Balabanov3, Hongbo Chi4, Lieping Chen5, Dario A A Vignali6,7, Stephen D Miller8.   

Abstract

The potent immune regulatory function of an agonistic B7-H4-Ig fusion protein (B7-H4Ig) has been demonstrated in multiple experimental autoimmune models; however, the identity of a functional B7-H4 receptor remained unknown. The biological activity of B7-H4 is associated with decreased inflammatory CD4+ T cell responses as supported by a correlation between B7-H4-expressing tumor-associated macrophages and Foxp3+ T cells within the tumor microenvironment. Recent data indicate that members of the semaphorin (Sema)/plexin/neuropilin (Nrp) family of proteins both positively and negatively modulate immune cell function. In this study, we show that B7-H4 binds the soluble Sema family member Sema3a. Additionally, B7-H4Ig-induced inhibition of inflammatory CD4+ T cell responses is lost in both Sema3a functional mutant mice and mice lacking Nrp-1 expression in Foxp3+ T cells. These findings indicate that B7-H4Ig binds to Sema3a, which acts as a functional bridge to stimulate an Nrp-1/Plexin A4 heterodimer to form a functional immunoregulatory receptor complex resulting in increased levels of phosphorylated PTEN and enhanced regulatory CD4+ T cell number and function.
Copyright © 2018 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29898965      PMCID: PMC6894186          DOI: 10.4049/jimmunol.1700811

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  43 in total

1.  B7S1, a novel B7 family member that negatively regulates T cell activation.

Authors:  Durbaka V R Prasad; Sabrina Richards; Xoi Muoi Mai; Chen Dong
Journal:  Immunity       Date:  2003-06       Impact factor: 31.745

2.  B7-H4.Ig inhibits the development of type 1 diabetes by regulating Th17 cells in NOD mice.

Authors:  I-Fang Lee; Xiaojie Wang; Jianqiang Hao; Noushin Akhoundsadegh; Lieping Chen; Linda Liu; Sol Langermann; Dawei Ou; Garth L Warnock
Journal:  Cell Immunol       Date:  2013-04-04       Impact factor: 4.868

3.  B7-H4 expression in various tumors determined using a novel developed monoclonal antibody.

Authors:  Yun Qian; Ling Shen; Linfang Cheng; Zhigang Wu; Hangping Yao
Journal:  Clin Exp Med       Date:  2010-12-29       Impact factor: 3.984

Review 4.  The role of immune semaphorins in multiple sclerosis.

Authors:  Tatsusada Okuno; Yuji Nakatsuji; Atsushi Kumanogoh
Journal:  FEBS Lett       Date:  2011-03-22       Impact factor: 4.124

5.  Neuropilin is a receptor for the axonal chemorepellent Semaphorin III.

Authors:  Z He; M Tessier-Lavigne
Journal:  Cell       Date:  1997-08-22       Impact factor: 41.582

6.  Neuropilin-1 attenuates autoreactivity in experimental autoimmune encephalomyelitis.

Authors:  Benjamin D Solomon; Cynthia Mueller; Wook-Jin Chae; Leah M Alabanza; Margaret S Bynoe
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-18       Impact factor: 11.205

7.  B7-H4, a molecule of the B7 family, negatively regulates T cell immunity.

Authors:  Gabriel L Sica; In Hak Choi; Gefeng Zhu; Koji Tamada; Sheng Dian Wang; Hideto Tamura; Andrei I Chapoval; Dallas B Flies; Jürgen Bajorath; Lieping Chen
Journal:  Immunity       Date:  2003-06       Impact factor: 31.745

8.  Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens.

Authors:  Matthew M Gubin; Xiuli Zhang; Heiko Schuster; Etienne Caron; Jeffrey P Ward; Takuro Noguchi; Yulia Ivanova; Jasreet Hundal; Cora D Arthur; Willem-Jan Krebber; Gwenn E Mulder; Mireille Toebes; Matthew D Vesely; Samuel S K Lam; Alan J Korman; James P Allison; Gordon J Freeman; Arlene H Sharpe; Erika L Pearce; Ton N Schumacher; Ruedi Aebersold; Hans-Georg Rammensee; Cornelis J M Melief; Elaine R Mardis; William E Gillanders; Maxim N Artyomov; Robert D Schreiber
Journal:  Nature       Date:  2014-11-27       Impact factor: 49.962

9.  A forward genetic screen in mice identifies Sema3A(K108N), which binds to neuropilin-1 but cannot signal.

Authors:  Janna Merte; Qiang Wang; Craig W Vander Kooi; Sarah Sarsfield; Daniel J Leahy; Alex L Kolodkin; David D Ginty
Journal:  J Neurosci       Date:  2010-04-21       Impact factor: 6.167

10.  Stability and function of regulatory T cells is maintained by a neuropilin-1-semaphorin-4a axis.

Authors:  Greg M Delgoffe; Seng-Ryong Woo; Meghan E Turnis; David M Gravano; Cliff Guy; Abigail E Overacre; Matthew L Bettini; Peter Vogel; David Finkelstein; Jody Bonnevier; Creg J Workman; Dario A A Vignali
Journal:  Nature       Date:  2013-08-04       Impact factor: 49.962

View more
  15 in total

1.  Plexin-A4 Mediates Cytotoxic T-cell Trafficking and Exclusion in Cancer.

Authors:  Ward Celus; Ana I Oliveira; Silvia Rivis; Heleen H Van Acker; Ewout Landeloos; Jens Serneels; Sarah Trusso Cafarello; Yannick Van Herck; Roberta Mastrantonio; Arnaud Köhler; Abhishek D Garg; Véronique Flamand; Luca Tamagnone; Jean-Christophe Marine; Mario Di Matteo; Bruno M Costa; Oliver Bechter; Massimiliano Mazzone
Journal:  Cancer Immunol Res       Date:  2021-11-23       Impact factor: 12.020

Review 2.  The B7x Immune Checkpoint Pathway: From Discovery to Clinical Trial.

Authors:  Peter John; Yao Wei; Weifeng Liu; Meirong Du; Fangxia Guan; Xingxing Zang
Journal:  Trends Pharmacol Sci       Date:  2019-10-31       Impact factor: 14.819

3.  Semaphorin3A increases M1-like microglia and retinal ganglion cell apoptosis after optic nerve injury.

Authors:  Liu Yun-Jia; Chen Xi; Zhang Jie-Qiong; Zhu Jing-Yi; Lin Sen; Ye Jian
Journal:  Cell Biosci       Date:  2021-05-26       Impact factor: 7.133

4.  Antibody targeting of B7-H4 enhances the immune response in urothelial carcinoma.

Authors:  Joseph R Podojil; Alexander P Glaser; Dylan Baker; Elise T Courtois; Damiano Fantini; Yanni Yu; Valerie Eaton; Santhosh Sivajothi; Mingyi Chiang; Arighno Das; Kimberly A McLaughlin; Paul Robson; Stephen D Miller; Joshua J Meeks
Journal:  Oncoimmunology       Date:  2020-04-16       Impact factor: 8.110

5.  Tumor cell expression of B7-H4 correlates with higher frequencies of tumor-infiltrating APCs and higher CXCL17 expression in human epithelial ovarian cancer.

Authors:  Heather L MacGregor; Carlos Garcia-Batres; Azin Sayad; Andrew Elia; Hal K Berman; Aras Toker; Sarah Rachel Katz; Patricia A Shaw; Blaise A Clarke; Sarah Q Crome; Celine Robert-Tissot; Marcus Q Bernardini; Linh T Nguyen; Pamela S Ohashi
Journal:  Oncoimmunology       Date:  2019-09-30       Impact factor: 8.110

Review 6.  The influence of microenvironment on tumor immunotherapy.

Authors:  Jieying Zhang; Zhaopeng Shi; Xiang Xu; Zuoren Yu; Jun Mi
Journal:  FEBS J       Date:  2019-08-22       Impact factor: 5.542

Review 7.  Neuropilin-1: A Key Protein to Consider in the Progression of Pediatric Brain Tumors.

Authors:  Manon Douyère; Pascal Chastagner; Cédric Boura
Journal:  Front Oncol       Date:  2021-07-01       Impact factor: 6.244

8.  Pharmacologic Suppression of B7-H4 Glycosylation Restores Antitumor Immunity in Immune-Cold Breast Cancers.

Authors:  Xinxin Song; Zhuan Zhou; Hongchun Li; Yifan Xue; Xinghua Lu; Ivet Bahar; Oliver Kepp; Mien-Chie Hung; Guido Kroemer; Yong Wan
Journal:  Cancer Discov       Date:  2020-09-16       Impact factor: 38.272

Review 9.  Cell guidance ligands, receptors and complexes - orchestrating signalling in time and space.

Authors:  Daniel Rozbesky; Edith Yvonne Jones
Journal:  Curr Opin Struct Biol       Date:  2019-12-17       Impact factor: 6.809

10.  High expression of B7-H3 on stromal cells defines tumor and stromal compartments in epithelial ovarian cancer and is associated with limited immune activation.

Authors:  Heather L MacGregor; Azin Sayad; Andrew Elia; Ben X Wang; Sarah Rachel Katz; Patricia A Shaw; Blaise A Clarke; Sarah Q Crome; Celine Robert-Tissot; Marcus Q Bernardini; Linh T Nguyen; Pamela S Ohashi
Journal:  J Immunother Cancer       Date:  2019-12-31       Impact factor: 13.751

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.